These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 8804418

  • 1. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
    Behrendt N, Danø K.
    FEBS Lett; 1996 Sep 09; 393(1):31-6. PubMed ID: 8804418
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC.
    Eur J Biochem; 1997 Apr 15; 245(2):316-23. PubMed ID: 9151959
    [Abstract] [Full Text] [Related]

  • 3. Functional analysis of the cellular receptor for urokinase in plasminogen activation. Receptor binding has no influence on the zymogenic nature of pro-urokinase.
    Ellis V.
    J Biol Chem; 1996 Jun 21; 271(25):14779-84. PubMed ID: 8662951
    [Abstract] [Full Text] [Related]

  • 4. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep 21; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 5. Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).
    Behrendt N, Danø K.
    FEBS Lett; 1997 Feb 03; 402(2-3):293-4. PubMed ID: 9037213
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
    Conese M, Blasi F.
    Biol Chem Hoppe Seyler; 1995 Mar 14; 376(3):143-55. PubMed ID: 7612191
    [Abstract] [Full Text] [Related]

  • 12. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T, Akakura N, Majumdar M, Andronicos N, Takagi J, Mazar AP, Bdeir K, Kuo A, Yarovoi SV, Cines DB, Takada Y.
    Thromb Haemost; 2006 Mar 14; 95(3):524-34. PubMed ID: 16525582
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Commentary on: 'Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system' by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31-36.
    Higazi AA.
    FEBS Lett; 1997 Feb 03; 402(2-3):291-2. PubMed ID: 9037212
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.
    Sidenius N, Andolfo A, Fesce R, Blasi F.
    J Biol Chem; 2002 Aug 02; 277(31):27982-90. PubMed ID: 12034711
    [Abstract] [Full Text] [Related]

  • 18. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
    Ellis V, Danø K.
    Biochem J; 1993 Dec 01; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
    [Abstract] [Full Text] [Related]

  • 19. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
    Magdolen V, Bürgle M, de Prada NA, Schmiedeberg N, Riemer C, Schroeck F, Kellermann J, Degitz K, Wilhelm OG, Schmitt M, Kessler H.
    Biol Chem; 2001 Aug 01; 382(8):1197-205. PubMed ID: 11592401
    [Abstract] [Full Text] [Related]

  • 20. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
    Rettenberger P, Wilhelm O, Oi H, Weidle UH, Goretzki L, Koppitz M, Lottspeich F, König B, Pessara U, Kramer MD.
    Biol Chem Hoppe Seyler; 1995 Oct 01; 376(10):587-94. PubMed ID: 8590627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.